Clinical trials: CPP
Pelvis Pain Chronic
Duloxetine for the Treatment of Chronic Pelvic Pain
This study is examining the effectiveness of duloxetine as a treatment for chronic pelvic pain in women. Duloxetine is FDA approved for the treatment of other pain conditions, including fibromyalgia and diabetic neuropathy.
- Trial name
- NCT01451606
- Testing
- Duloxetine
- Where
- United States
- Volunteers
- 34 people
- Sponsor
- University of Maryland, Baltimore
Atypical Choroid Plexus Papilloma, Choroid Plexus Carcinoma
Intra-Arterial Chemotherapy for Newly Diagnosed, Residual, or Recurrent Atypical Choroid Plexus Papilloma and Choroid Plexus Carcinoma Prior to Second-Look Surgery
This study will test the safety and efficacy of intra-arterial chemotherapy in subjects with newly diagnosed, residual, or recurrent atypical choroid plexus papilloma and choroid plexus carcinoma prior to a second surgery.
- Trial name
- NCT04994977
- Testing
- Melphalan, Carboplatin, Topotecan
- Where
- United States
- Volunteers
- 1 people
- Sponsor
- Weill Medical College of Cornell University
Dentin Sensitivity, Molar Incisor Hypomineralization
MIH and Hypersensitivity in Children
The aim of this study was to evaluate the efficacy of the association of casein phosphopeptide plus amorphous calcium phosphate (CPP-ACPF) mousse and photo-bio-modulation therapy (PMBT) (diode laser, RAFFAELLO 980 BIO - Dental…
- Trial name
- NCT05705037
- Testing
- CPP-ACPF, PBMT, CPP-ACPF+PBMT
- Where
- Italy
- Volunteers
- 39 people, healthy volunteers welcome
- Sponsor
- Università degli Studi di Brescia
Chronic Pain
Electro-acupuncture (EA) and Chronic Pelvic Pain (CPP)
Chronic pelvic pain (CPP) is a debilitating condition that affects over 1 million women in the United Kingdom. The annual healthcare costs are estimated at over £150 million.
- Trial name
- BMEA (NCT02295111)
- Testing
- EA treatment, TCM health consult, Usual Care
- Where
- United Kingdom
- Volunteers
- 30 people
- Sponsor
- University of Edinburgh